[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.172.233.215. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Original Contribution
January 2010

Interferon-γ–Producing T Cells, Pregnancy, and Postpartum Relapses of Multiple Sclerosis

Author Affiliations

Author Affiliations: Department of Health Research and Policy (Drs Langer-Gould, Huang, and Nelson, Mr Gupta, and Ms Greenwood), School of Medicine, and Department of Genetics (Dr Atkuri), Stanford University, Stanford, Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena (Drs Langer-Gould, Hagan, and Steinman), and Division of Research, Kaiser Permanente Northern California, Oakland (Mss Leimpeter and Albers and Dr Van Den Eeden). Dr Huang is now with Touro University College of Osteopathic Medicine, New York, New York.

Arch Neurol. 2010;67(1):51-57. doi:10.1001/archneurol.2009.304
Abstract

Objective  To determine whether fluctuations in functional T-cell subsets can explain why multiple sclerosis (MS) relapses decline during pregnancy and increase in the postpartum period.

Design  Case-control study.

Setting  Kaiser Permanente Northern California and Stanford University.

Participants  Twenty-six pregnant women with MS and 24 age-matched, pregnant controls.

Intervention  We prospectively followed up the pregnant women with MS and the age-matched, pregnant controls; conducted structured interviews; and collected peripheral blood mononuclear cells during each trimester and 2, 4, 6, 9, and 12 months post partum.

Main Outcome Measures  Sixteen functional cell types, including interferon-γ (IFN-γ)– and tumor necrosis factor–producing T-cell subsets, were measured using multicolor flow cytometry. Since these cell types may also fluctuate with pregnancy, lactational amenorrhea, or MS treatment, the data were analyzed taking into account these factors.

Results  Fifteen women with MS (58%) had relapses during the postpartum year. CD4+IFN-γ–producing cells fluctuated with MS relapses, declining during pregnancy in women with MS (P < .001) and continuing to decline after parturition in women with relapses (P = .001), yet rising or remaining stable in women with nonrelapsing MS or healthy pregnant women. Lactational amenorrhea was associated with a rise in CD4+IFN-γ–producing cells in women with MS (P = .009). In contrast, CD4+ tumor necrosis factor–producing cells decreased during lactational amenorrhea in all groups of women and, once this was taken into account, obscured any relationship to MS relapses. CD8+IFN-γ–producing cells were elevated in women with MS throughout the study (P < .001) but did not fluctuate with relapses.

Conclusions  Our findings suggest that a decline in circulating CD4+IFN-γ–producing cells leads to postpartum MS relapses. Our findings also suggest that the decline in these cells may begin during late pregnancy and that lactational amenorrhea induced by exclusive breastfeeding may be able to interrupt this process.

×